Buscar
Mostrando ítems 81-90 de 488
Linfoma de Hodgkin: características anátomo-clínicas e análise de novo biomarcador (IMP3)
(Universidade Estadual Paulista (Unesp), 2015-02-19)
Hodgkin lymphoma (HL) is a hematopoietic neoplasm that characteristically affects young adults and, if untreated, presents a fatal clinical course. Early and accurate diagnosis of this lymphoma associated with modern ...
Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: High frequency of a 30-bp deletion
(W B Saunders Co, 1997-12-01)
A 30-basepair (bp) deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) gene has been reported in nasopharyngeal carcinoma and EBV-associated malignant lymphomas. Prior studies have found the deletion ...
Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: High frequency of a 30-bp deletion
(W B Saunders Co, 1997-12-01)
A 30-basepair (bp) deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) gene has been reported in nasopharyngeal carcinoma and EBV-associated malignant lymphomas. Prior studies have found the deletion ...
Avaliação de cardiotoxicidade subclínica tardia em pacientes com diagnóstico prévio de linfoma não Hodgkin tratados com antraciclinas
(Universidade Estadual Paulista (Unesp), 2015-02-23)
Background: late cardiotoxicity in non-Hodgkin lymphoma survivors (NHL) treated with anthracycline is manifested by heart failure (HF), defined by reduced left ventricular ejection fraction (LVEF). These patients may show ...
Pegivirus humano: Potencial patogénico y riesgo de desarrollo de linfoma no HodgkinHuman Pegivirus: Pathogenic Potential and non-Hodgkin Lymphoma Development Risk
(Sociedad Chilena de InfectologíaGrupo de GastrohepatologíaSantiago de Chile, Chile, 2023)
O transplante de células-tronco hematopoéticas no tratamento dos linfomas não HodgkinHematopoietic stem cell transplantation for non-Hodgkin lymphomas
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2010)